Spots Global Cancer Trial Database for carcinomatosis
Every month we try and update this database with for carcinomatosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) | NCT03956836 | Coagulation Dis... Carcinomatosis | ROTEM parameter... | 18 Years - | Hospitales Universitarios Virgen del Rocío | |
| A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT05977998 | Gastric Adenoca... Carcinomatosis | Paclitaxel Dexamethasone Diphenhydramine Famotidine | 18 Years - | M.D. Anderson Cancer Center | |
| Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC | NCT04104334 | Hyperthermia Colorectal Neop... Oxaliplatin | Remifentanil in... Remifentanil in... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma. | NCT05340569 | Pancreas Cancer... Pancreas Adenoc... Peritoneal Meta... Peritoneal Carc... | Whole-body diff... | 18 Years - | Laval University | |
| Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis | NCT01342653 | Peritoneal Carc... Gastric Cancer | Intraperitoneal... | 18 Years - 64 Years | Hospital General Universitario Gregorio Marañon | |
| Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
| Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
| Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT02659241 | Advanced Fallop... Advanced Ovaria... Advanced Primar... Carcinomatosis Fallopian Tube ... Ovarian High Gr... Primary Periton... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... | Adavosertib Laboratory Biom... | 18 Years - | M.D. Anderson Cancer Center | |
| Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | NCT02948426 | Fallopian Tube ... Ovarian Cancer Primary Periton... | Autologous Mono... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology | NCT05977998 | Gastric Adenoca... Carcinomatosis | Paclitaxel Dexamethasone Diphenhydramine Famotidine | 18 Years - | M.D. Anderson Cancer Center | |
| Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis | NCT00216372 | Intestinal Obst... Carcinoma Peritoneal Neop... | Lanreotide (mic... Placebo | 18 Years - | Ipsen | |
| Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis | NCT00332696 | Peritoneal Neop... Intestinal Obst... Carcinomatosis | Octreotide LAR Octreotide (Imm... methylprednisol... Placebo | 18 Years - | Novartis | |
| Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) | NCT03956836 | Coagulation Dis... Carcinomatosis | ROTEM parameter... | 18 Years - | Hospitales Universitarios Virgen del Rocío | |
| Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms | NCT05623787 | Peritoneal Carc... Peritoneal Meta... Appendix Cancer Appendix Neopla... Colorectal Canc... | Whole-body diff... | 18 Years - | Laval University | |
| Immunologic Profile of Peritoneal Cancer | NCT03230240 | Carcinomatosis | HIPEC | 18 Years - 99 Years | MercyOne Des Moines Medical Center | |
| Immunologic Profile of Peritoneal Cancer | NCT03230240 | Carcinomatosis | HIPEC | 18 Years - 99 Years | MercyOne Des Moines Medical Center | |
| Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis | NCT06365918 | Advanced Solid ... Carcinomatosis | VG2025 | 18 Years - | M.D. Anderson Cancer Center | |
| B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | NCT01150916 | Heart Failure Liver Cirrhosis Ascites Carcinomatosis | BNP, SAAG, asci... | 18 Years - | University of Sao Paulo | |
| B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | NCT01150916 | Heart Failure Liver Cirrhosis Ascites Carcinomatosis | BNP, SAAG, asci... | 18 Years - | University of Sao Paulo | |
| Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin | NCT02017678 | Ovarian Cancer | JX-594 | 18 Years - | Mount Sinai Hospital, Canada | |
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | NCT05083338 | Appendix Carcin... Carcinomatosis Colorectal Carc... Gastric Carcino... Malignant Perit... Malignant Solid... | Biospecimen Col... Pain Assessment Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy | NCT05083338 | Appendix Carcin... Carcinomatosis Colorectal Carc... Gastric Carcino... Malignant Perit... Malignant Solid... | Biospecimen Col... Pain Assessment Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer | NCT03922776 | Ovarian Cancer ... Fallopian Tube ... Fallopian Tube ... Ovarian Cancer ... | Blood sample co... | 18 Years - | Centre Oscar Lambret | |
| Immunologic Profile of Peritoneal Cancer | NCT03230240 | Carcinomatosis | HIPEC | 18 Years - 99 Years | MercyOne Des Moines Medical Center | |
| Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis | NCT05541146 | Gastric Cancer Peritoneal Carc... | Intraperitoneal... | 18 Years - 75 Years | Instituto do Cancer do Estado de São Paulo | |
| Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis | NCT06365918 | Advanced Solid ... Carcinomatosis | VG2025 | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
